#ASCO16 news about #melanoma #skincancer

#keytruda shows some early benefit in some but not all sarcoma patients –Dr D'Angelo #asco16 pic.twitter.com/dtbGrmzhJj

— Eric D Whitman, MD (@Melanoma_doctor) June 5, 2016